Pacer Advisors Inc. Raises Holdings in CME Group Inc. (NASDAQ:CME)

Pacer Advisors Inc. increased its position in CME Group Inc. (NASDAQ:CMEFree Report) by 27.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 46,508 shares of the financial services provider’s stock after purchasing an additional 9,905 shares during the period. Pacer Advisors Inc.’s holdings in CME Group were worth $10,262,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Harbor Capital Advisors Inc. increased its holdings in shares of CME Group by 0.6% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after acquiring an additional 45 shares during the period. CVA Family Office LLC grew its position in CME Group by 11.8% during the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after purchasing an additional 46 shares during the last quarter. Lester Murray Antman dba SimplyRich increased its stake in CME Group by 0.7% in the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after purchasing an additional 50 shares during the period. Zions Bancorporation N.A. raised its holdings in shares of CME Group by 3.7% in the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after buying an additional 54 shares during the last quarter. Finally, Quent Capital LLC boosted its stake in shares of CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after buying an additional 55 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling

In other news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 5.38 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 12.01 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 in the last three months. Corporate insiders own 0.30% of the company’s stock.

Analysts Set New Price Targets

Several research firms have commented on CME. Bank of America upped their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. Piper Sandler increased their price target on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a report on Monday, October 28th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Oppenheimer raised their target price on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Finally, Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a report on Tuesday, October 8th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $224.47.

Get Our Latest Report on CME Group

CME Group Trading Up 1.1 %

Shares of CME opened at $229.04 on Friday. The firm’s 50-day moving average is $223.64 and its two-hundred day moving average is $211.09. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.74. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a market capitalization of $82.54 billion, a P/E ratio of 24.08, a PEG ratio of 5.23 and a beta of 0.55.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company’s revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.25 EPS. On average, research analysts predict that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be given a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.01%. CME Group’s dividend payout ratio is presently 48.37%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.